InsiderClue
Insiders · Profile

Chevallard Daniel R.

Chief Financial Officer at LENZ Therapeutics. Filing since 14 May 2024. CIK 0001706176

Company
Date
Role
Action
Shares
Amount
Of holding
LENZ LENZ Therapeutics, Inc.
27 Mar 2026
Chief Financial Officer
Bought
7,500
$64.28K
139%
LENZ LENZ Therapeutics, Inc.
7 Nov 2025
Chief Financial Officer
Bought
2,198
$50.02K
68.9%
LENZ LENZ Therapeutics, Inc.
14 May 2024
Chief Financial Officer
Bought
3,188
$49.99K
opened
3 decisions on file.